Neurofibromatosis Type II
3 clinical trials · Condition
◉ Watch Neurofibromatosis Type II
| Record | Firm | Date |
|---|---|---|
| Familial Investigations of Childhood Cancer Predisposition (NCT03050268) | St. Jude Children's Research Hospital | 2017-04-06 |
| Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2 (NCT01419639) | NYU Langone Health | 2011-10-01 |
Track Neurofibromatosis Type II automatically
Every clearance here is in the API, with alerts when new ones post.